Padmaja Rajagopal Sankaridurg

This inventor holds 38 USPTO granted patents and 14 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Myopia Control. Top assignees: Brien Holden Vision Institute Limited, Vision Crc Limited, Novartis Ag. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Padmaja Rajagopal Sankaridurg. Retrieved from https://idiyas.com/inventor/padmaja-rajagopal-sankaridurg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 38 (Patent Applications = 14)

% Patents Active = 92.1

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 5.1

ph-index = 11

Forward Citations = 493(Granted Patents)

Location History:

Marboubra, AU (2010 - 2014)
Maraubra, AU (2019 - 2022)
Maroubra, AU (2011 - 2024)
Sydney, AU (2015 - 2024)
Marouba, AU (2022 - 2024)

Company Filing History:

31 out of 93

Brien Holden Vision Institute Limited

The Institute for Eye Research Limited

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Myopia Control

Ocular Refractive Error

Contact Lenses

Vision Correction

Corneal Remodelling

Atropine

Peripheral Vision

Progression Control

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12566339 - Treating ocular refractive error (2026-03-03),

2. 12386203 - Devices, systems and/or methods for myopia control (2025-08-12),

3. 12372811 - Ophthalmic optical lens for vision correction having one or more areas of more positive power (2025-07-29),

4. 12306473 - Means for controlling the progression of myopia (2025-05-20),

5. 12271059 - Contact lenses for myopic eyes and methods of treating myopia (2025-04-08),

6. 12061383 - Devices, systems and/or methods for myopia control (2024-08-13),

7. 12019313 - Lens for myopic eye (2024-06-25),

8. 11874532 - Devices, systems and/or methods for myopia control (2024-01-16),

9. 11874529 - Ophthalmic optical lens for vision correction having one or more areas of more positive power (2024-01-16),

10. 11813197 - Ophthalmic lenses and methods for correcting, slowing, reducing, and/or controlling the progression of myopia in conjunction with use of atropine or related compounds (2023-11-14),

11. 11796839 - Contact lenses for myopic eyes and methods of treating myopia (2023-10-24),

12. 11567347 - Systems, methods and devices for controlling the progression of myopia (2023-01-31),

13. 11467424 - Means for controlling the progression of myopia (2022-10-11),

14. 11402663 - Treating ocular refractive error (2022-08-02),

15. 11234862 - Ophthalmic lenses and methods for correcting, slowing, reducing, and/or controlling the progression of myopia in conjunction with use of atropine or related compounds (2022-02-01),

Title: Innovations in Myopia Control by Padmaja Rajagopal Sankaridurg

Introduction

Padmaja Rajagopal Sankaridurg, based in Maroubra, Australia, is a prominent inventor in the field of ophthalmic technology. With an impressive portfolio of 33 patents, she has made significant contributions to innovations aimed at myopia control, helping to address the growing concern of vision impairment worldwide.

Latest Patents

Sankaridurg's latest patents focus on devices, systems, and methods for myopia control. One notable innovation includes a lens that conveys a stop signal to a myopic eye using a micro lenslet array. This technology is designed to impose limits on eye growth through clever manipulation of incoming light, utilizing chromatic cues to slow the progression of myopia. Another significant development is her ophthalmic lens element, which features a dual-zoned structure, providing a distance viewing zone with specific refractive powers for clear vision, and a near viewing zone that compensates for accommodative lag.

Career Highlights

Throughout her career, Padmaja has made notable strides in vision science, having worked at esteemed organizations such as the Brien Holden Vision Institute and Vision CRC Limited. Her dedication to research and innovation in myopia control demonstrates her commitment to advancing eye care technology and improving visual health.

Collaborations

Sankaridurg has collaborated with influential figures in her field, including colleagues such as Arthur Ho and Brien Anthony Holden. Their combined expertise has propelled advancements in ophthalmic technology, showcasing the importance of teamwork in driving innovation.

Conclusion

Padmaja Rajagopal Sankaridurg's contributions to myopia control innovations have established her as a leading inventor in ophthalmic technology. Her continued work not only aids individuals with visual impairments but also shapes the future of eye care through pioneering inventions.

Profile summary based on public USPTO records.